XML 23 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Revenues
6 Months Ended
Jun. 30, 2021
Revenues  
Revenues

3.     Revenues

As discussed in Note 2, revenues are recognized under guidance within ASC 606. The following table presents our disaggregated revenue for the periods presented (in thousands):

Three Months Ended

Six Months Ended

    

June 30,

    

June 30,

    

2021

2020

2021

2020

JAKAFI revenues, net

$

529,055

$

473,706

$

994,765

$

933,185

ICLUSIG revenues, net

28,189

22,798

53,834

50,046

PEMAZYRE revenues, net

17,906

3,786

31,362

3,786

Total product revenues, net

575,150

500,290

1,079,961

987,017

JAKAVI product royalty revenues

82,038

66,217

147,640

122,550

OLUMIANT product royalty revenues

36,045

25,830

68,303

51,277

TABRECTA product royalty revenues

2,476

706

4,523

706

Total product royalty revenues

120,559

92,753

220,466

174,533

Milestone and contract revenues

10,000

95,000

10,000

95,000

Total revenues

$

705,709

$

688,043

$

1,310,427

$

1,256,550

For further information on our revenue-generating contracts, refer to Note 9.